D. Managing Access
There are many approaches to managing or enhancing access to HTA reports. As noted above, some HTA reports are public documents available at no cost via the Internet or other public sources, while others are available only to paid subscribers or membership organizations. Others are for internal use only and not made public. Access to HTA reports and related literature is also subject to the capacity, policies, and priorities of bibliographic organizations (e.g., the US National Library of Medicine and commercial database vendors) regarding the scope of their online databases and other information sources (e.g., inclusion of peer-reviewed journals, grey literature, or other sources) and capacity to index the literature. Also, the word choice of HTA authors for report titles and abstracts can influence the indexing (e.g., designation of MeSH terms and other controlled vocabularies) and retrieval of HTA reports. Over time, these controlled vocabularies evolve with the terminology used in the field of HTA, toward improvement of indexing and retrieval.
References for Chapter VIII
Ackerly DC, Glickman SW, Schulman KA. Economic content in medical journal advertisements for medical devices and prescription drugs. Pharmacoeconomics. 2010;28(5):429-38. PubMed
Atherly A, Rubin PH. The cost-effectiveness of direct-to-consumer advertising for prescription drugs. Med Care Res Rev. 2009;66(6):639-57. PubMed
Battista RN, Hodge MJ. The ”natural history” of health technology assessment. Int J Technol Assess Health Care. 2009;25 Suppl 1:281-4. PubMed
Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357(7):673-81. PubMed | Publisher free article.
Eguale T, Buckeridge DL, Winslade NE, Benedetti A, et al. Drug, patient, and physician characteristics associated with off-label prescribing in primary care. Arch Intern Med. 2012;172(10):781-8. PubMed
EUnetHTA (European Network for Health Technology Assessment). HTA Core Model for Medical and Surgical Interventions Version 1.0 Work Package 4. The HTA Core Model. December 2008. Publisher free report.
Farmer AP, Légaré F, Turcot L, Grimshaw J, et al. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2008;(3):CD004398. PubMed
Fattal J, Lehoux P. Health technology assessment use and dissemination by patient and consumer groups: why and how? Int J Technol Assess Health Care. 2008;24(4):473-80. PubMed
Fischer MA, Avorn J. Academic detailing can play a key role in assessing and implementing comparative effectiveness research findings. Health Aff (Millwood). 2012;31(10):2206-12. PubMed
Flodgren G, Parmelli E, Doumit G, Gattellari M, et al. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2011;(8):CD000125. PubMed | PMC free article
Forsetlund L, Bjørndal A, Rashidian A, Jamtvedt G, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2009;(2):CD003030. PubMed
Gilhooley M. Commercial speech and off-label drug uses: what role for wide acceptance, general recognition and research incentives? Am J Law Med. 2011;37(2-3):258-77. PubMed
Hivon M, Lehoux P, Denis JL, Tailliez S. Use of health technology assessment in decision making: coresponsibility of users and producers? Int J Technol Assess Health Care. 2005;21(2):268-75. PubMed
INAHTA. International Network of Agencies in Health Technology Assessment Secretariat. A Checklist for Health Technology Assessment Reports. Version 3.2. August 2007. Accessed March 22, 2016 at: http://www.inahta.org/wp-content/uploads/2014/04/INAHTA_HTA_Checklist_English.pdf.
Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2006;(2):CD000259. PubMed
Kahan JP, Kanouse DE, Winkler JD. Stylistic variations in National Institutes of Health consensus statements, 1979-1983. Int J Technol Assess Health Care. 1988;4(2):289-304. PubMed
Lehoux P, Denis JL, Tailliez S, Hivon M. Dissemination of health technology assessments: identifying the visions guiding an evolving policy innovation in Canada. J Health Polit Policy Law. 2005;30(4):603-41. PubMed
Lehoux P, Tailliez S, Denis JL, Hivon M. Redefining health technology assessment in Canada: diversification of products and contextualization of findings. Int J Technol Assess Health Care. 2004;20(3):325-36. PubMed
Liu Y, Doucette WR. Does direct-to-consumer advertising affect patients' choice of pain medications? Curr Pain Headache Rep. 2008;12(2):89-93. PubMed
Lyles A. Direct marketing of pharmaceuticals to consumers. Annu Rev Public Health. 2002;23:73-91. PubMed
Mali SN, Dudhgaonkar S, Bachewar NP. Evaluation of rationality of promotional drug literature using World Health Organization guidelines. Indian J Pharmacol. 2010;42(5):267-72. PubMed | PMC free article.
Mintzes B, Morgan S, Wright JM. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale. PLoS One. 2009;4(5):e5699. PubMed | PMC free article.
Neumann PJ, Claxton K, Weinstein MC. The FDA's regulation of health economic information. Health Aff (Millwood). 2000;19(5):129-37. http://content.healthaffairs.org/content/19/5/129.long. PubMed
O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007;(4):CD000409. PubMed
Palmer JA, Timm AR, Neumann PJ. Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999. J Manag Care Pharm. 2008;14(8):749-55. PubMed
Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166(9):1021-6. PubMed
Reeves S, Perrier L, Goldman J, Freeth D, Zwarenstein M. Interprofessional education: effects on professional practice and healthcare outcomes (update). Cochrane Database Syst Rev. 2013 Mar 28;3:CD002213. PubMed
Sobrido Prieto M, Gonzalez Guitian C, Cerda Mota T. Strategies for the diffusion and dissemination of health technology assessment (HTA) products. Santiago de Compostela: Galician Agency for Health Technology Assessment (AVALIA-T). avalia-t No 2007-072009; 2007. Publisher free report.
Solomon DH, Van Houten L, Glynn RJ, Baden L. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001;161(15):1897-902. PubMed
Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990;263(4):549-56. PubMed
US Food and Drug Administration. Guidance for Industry - Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices. January 2009. Accessed November 27, 2013, at: http://www.fda.gov/RegulatoryInformation/Guidances/ucm125126.htm.
Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD000072. PubMed